LARRY BAYLIS: Open Payments
NPI 1902847510 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 99 payments from 24 companies in 2025. Trend: 2023 $1,632 · 2024 $1,541 · 2025 $1,798
Food & beverage: $1,798
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $337 |
| AstraZeneca Pharmaceuticals LP | 11 | $221 |
| Amgen Inc. | 16 | $165 |
| Antares Pharma, Inc. | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $107 |
| Astellas Pharma US Inc | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 5 | $79 |
| RGH Enterprises LLC | 2 | $66 |
| GlaxoSmithKline, LLC. | 3 | $64 |
Products named: Wegovy, Rybelsus, BREZTRI, XYOSTED, Kerendia, OTEZLA, Veozah, JARDIANCE.
Industry payments across MI — which companies pay providers there.
